PYVAX
Price
$19.06
Change
+$0.20 (+1.06%)
Updated
Sep 11 closing price
Net Assets
1.09B
RMFCX
Price
$63.49
Change
+$0.33 (+0.52%)
Updated
Sep 11 closing price
Net Assets
117.47B
Interact to see
Advertisement

PYVAX vs RMFCX

PYVAX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
PYVAX vs. RMFCX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYVAX is a Hold and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 117B vs. PYVAX (1.09B). RMFCX pays higher dividends than PYVAX: RMFCX (1.15) vs PYVAX (0.92). PYVAX was incepted earlier than RMFCX: PYVAX (15 years) vs RMFCX (24 years). PYVAX (1.01) is less costly to investors than RMFCX (0.91). PYVAX is a more actively managed with annual turnover of: 112.00 vs. RMFCX (30.00). RMFCX has a lower initial minimum investment than PYVAX: RMFCX (250) vs PYVAX (5000). PYVAX annual gain was more profitable for investors over the last year : 9.49 vs. RMFCX (4.75). RMFCX return over 5 years is better than : 35.61 vs. PYVAX (-1.66).
PYVAXRMFCXPYVAX / RMFCX
Total Expense Ratio1.010.91111%
Annual Report Gross Expense Ratio1.010.91111%
Fund Existence15 years24 years-
Gain YTD12.1578.539142%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B117B1%
Annual Yield % from dividends0.921.1580%
Returns for 1 year9.494.75200%
Returns for 3 years23.2635.3866%
Returns for 5 years-1.6635.61-5%
Returns for 10 years52.3394.1656%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABSYX28.430.20
+0.71%
American Beacon Small Cp Val Y
FFBGX42.740.01
+0.02%
American Funds Global Balanced 529-F-3
ABWCX16.38N/A
N/A
AB All Market Total Return C
SBASX14.25N/A
N/A
Segall Bryant &Hamill Small Cap Cre Ins
FCEUX21.84N/A
N/A
Franklin U.S. Core Equity Advisor